Earlier in the week, I posted an article in which I postulated that the widespread use of Hydroxychloroquine and Ivermectin in Africa to treat other diseases was inhibiting the spread of COVID-19 in that continent.
Thanks to a comment by reader Nahanni on another post yesterday, I was led to an article at NOQReport titled "Shocking Conclusions from Africa Study Expose Why Big Pharma’s Puppets are Suppressing Ivermectin Data". It predates my article, but I hadn't been aware of the study until Nahanni drew it to my attention. In so many words, the long article confirms my hypothesis. Here are a few excerpts. Bold, underlined text is my emphasis.
A graph made its rounds on social media yesterday that raised some eyebrows. It showed the clear difference between countries in Africa that use Ivermectin regularly versus those that do not. The differences were startling as the Ivermectin-nations showed unambiguous advantages against Covid-19. The mortality rates were very low compared to countries that do not use Ivermectin on a wide scale ... Universal Ivermectin use seems to be the only factor preventing these nations from a full-blown Covid-19 catastrophe.
. . .
The final and arguably most important “hidden” takeaway from the study is that recovery and fatality rates for Covid-19 cases were not statistically significantly different between Ivermectin countries and non-Ivermectin countries. That means that once a person was tested and officially declared a Covid-19 case, they recovered or died at essentially the same rates across the board.
This tells us that other factors such as medical proficiency, environmental differences, or access to vaccines do not contribute to whether someone lives or dies once they have become sick with the disease. Since overall mortality rates per capita are significantly lower in Ivermectin nations but case fatality rates are the same, Ivermectin is clearly effective as an early treatment and perhaps even as a preventative measure.
Remember, the people in the Ivermectin nations are already taking the drug. They aren’t waiting for a positive Covid test and likely aren’t even very concerned about the disease at all. Many if not most who do end up becoming Covid-19 cases in Ivermectin nations were likely among those who were not taking Ivermectin as an antiparasitic.
There's more at the link, including statistics, charts, etc.
I'm very glad to have independent confirmation of what was basically just a theory of mine, based on experience in Africa, but not supported by medical evidence. The latter is now available, and seems to support my theory. It's a warm fuzzy feeling to find that I was pretty much on the money.
I'd like to find out whether anyone's done a similar study on Hydroxychloroquine as a COVID-19 suppressant in Africa. So many millions of people take it there as an anti-malarial prophylactic medication that I'm certain it must be having that effect; but as yet I haven't found any investigations looking into whether that's affecting COVID-19 infection rates. I'm willing to bet that it is, as discussed in my earlier article.